Image

Effect of the Use of Specific Oral Hygiene Devices on Gingival Health Among Patients With Systemic Sclerosis

Recruiting
18 years of age
Both
Phase N/A

Overview

Systemic sclerosis is a rare multisystem connective-tissue disorder characterized by three major pathological hallmarks: widespread fibrosis, vasculopathy and immunological abnormalities. This condition has multiple effects on the orofacial region that is involved in approximately 80% of the patients with a significant impact on the quality of life.

The aim of this randomized single-blind study is to evaluate the impact of the use of a specific oral hygiene instrumentation (sonic toothbrush and water flosser with a large handle) compared to "standard" toothbrushing with a manual toothbrush on the gingival health among patients with systemic sclerosis.

Eligibility

Inclusion Criteria:

  • Adult male or female ≥ 18 years (18th birthday completed)
  • Affiliation to a social welfare system
  • Signed informed consent form
  • More than 12 natural teeth suitable for evaluation
  • Systemic sclerosis with cutaneous involvement with a diagnosis based on American College of Rheumatology (ACR) and LeRoy and Metzger criteria

Exclusion Criteria:

  • Localized scleroderma or systemic sclerosis without cutaneous involvement ("sine scleroderma" limited form)
  • Less than 12 natural teeth suitable for evaluation and/or mandibular/maxillary complete denture(s)
  • Other progressive chronic illness /autoimmune disease other than systemic sclerosis (e.g. diabetes)
  • Another cause of mucocutaneous sclerosis (e.g. radiotherapy involving the oro-facial region)
  • Current use of sonic toothbrush and/or dental water flosser
  • Severe manual handicap preventing the patient from holding a toothbrush with a large handle
  • Oral antiseptics (e.g. chlorhexidin mouthwashes)
  • Ongoing medical treatment inducing a significant modification of the gingival state (e.g. anti-epileptic drugs)
  • Smoking (≥ 10 cigarettes per day)
  • Impossibility to provide accurate information (e.g. emergency situation, comprehension difficulties)
  • Individual under guardianship, curatorship or judicial protection

Study details

Scleroderma Systemic

NCT04627857

University Hospital, Strasbourg, France

26 January 2024

Rewrite in simple language using AI

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.